title: Managing psoriasis: what's best for your patient?
abstract: Whether the symptoms are mild, moderate, or severe, the optimal treatment plan is the one the patient is most likely to follow.
authors: Northeast Ohio Medical University, Rootstown, OH, USA. eulenha@neomed.edu
authors: Elizabeth E
authors: EE
authors: Uhlenhake
authors: David A
authors: DA
authors: Mehregan
mesh_terms: D000279:Administration, Cutaneous; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003879:Dermatologic Agents / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D010778:Photochemotherapy; D011565:Psoriasis / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D014467:Ultraviolet Therapy
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D007166:Immunosuppressive Agents